1. Home
  2. NAMSW vs TALKW Comparison

NAMSW vs TALKW Comparison

Compare NAMSW & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • TALKW
  • Stock Information
  • Founded
  • NAMSW N/A
  • TALKW N/A
  • Country
  • NAMSW Netherlands
  • TALKW United States
  • Employees
  • NAMSW 29
  • TALKW 472
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • TALKW Medical/Nursing Services
  • Sector
  • NAMSW Health Care
  • TALKW Health Care
  • Exchange
  • NAMSW Nasdaq
  • TALKW Nasdaq
  • Market Cap
  • NAMSW N/A
  • TALKW N/A
  • IPO Year
  • NAMSW N/A
  • TALKW 2020
  • Fundamental
  • Price
  • NAMSW $8.90
  • TALKW $0.10
  • Analyst Decision
  • NAMSW
  • TALKW
  • Analyst Count
  • NAMSW 0
  • TALKW 0
  • Target Price
  • NAMSW N/A
  • TALKW N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • TALKW N/A
  • Earning Date
  • NAMSW N/A
  • TALKW N/A
  • Dividend Yield
  • NAMSW N/A
  • TALKW N/A
  • EPS Growth
  • NAMSW N/A
  • TALKW N/A
  • EPS
  • NAMSW N/A
  • TALKW N/A
  • Revenue
  • NAMSW N/A
  • TALKW N/A
  • Revenue This Year
  • NAMSW N/A
  • TALKW N/A
  • Revenue Next Year
  • NAMSW N/A
  • TALKW N/A
  • P/E Ratio
  • NAMSW N/A
  • TALKW N/A
  • Revenue Growth
  • NAMSW N/A
  • TALKW N/A
  • 52 Week Low
  • NAMSW N/A
  • TALKW N/A
  • 52 Week High
  • NAMSW N/A
  • TALKW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 46.37
  • TALKW N/A
  • Support Level
  • NAMSW $8.30
  • TALKW N/A
  • Resistance Level
  • NAMSW $9.77
  • TALKW N/A
  • Average True Range (ATR)
  • NAMSW 0.27
  • TALKW 0.00
  • MACD
  • NAMSW -0.10
  • TALKW 0.00
  • Stochastic Oscillator
  • NAMSW 28.57
  • TALKW 0.00

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: